Jae-Weon Kim

Professor

Seoul National University Hospital

South Korea

Research Interests

Explore related searches

Professors in South Korea Professors in Cancer Research Cancer Research professors in South Korea

About

Professor Jae-Weon Kim is a faculty member at Seoul National University Hospital in South Korea. His research primarily focuses on ovarian cancer, particularly in the areas of chemotherapy, immune checkpoint inhibitors, and precision medicine. Recent publications include studies on novel treatment combinations and neoadjuvant therapies for advanced ovarian cancer, reflecting his commitment to advancing gynecologic oncology. He actively contributes to the academic community, including participation in the Asian Society of Gynecologic Oncology's annual meeting.

Articles (22)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (24)

Patricia Roxburgh

University of Glasgow

UNITED KINGDOM

Jae-Weon Kim

Research Interests

Explore related searches

About

Articles (22)

Olaparib as Treatment Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer: Phase III SOLO3 Study Final Overall Survival Results

Neoadjuvant Chemotherapy with Dual Immune Checkpoint Inhibitors for Advanced-Stage Ovarian Cancer: Final Analysis of TRU-D Phase II Nonrandomized Clinical Trial

Primary Analysis of EPIK-O/ENGOT-ov61: Alpelisib Plus Olaparib Versus Chemotherapy in Platinum-Resistant or Platinum-Refractory High-Grade Serous Ovarian Cancer Without BRCA Mutation

Asian Society of Gynecologic Oncology (ASGO) 2024 Annual Meeting in Bali, Indonesia

Erratum: The Asia-Pacific Gynecologic Oncology Trials Group (APGOT): building a Pan-Asian and Oceania women’s cancer research organization

A phase 1/2a, dose-escalation, safety, and preliminary efficacy study of the RKP00156 vaginal tablet in healthy women and patients with cervical intraepithelial neoplasia 2

Chemotherapy response score no longer predicts survival outcomes in high-grade serous ovarian cancer patients with BRCA mutation and/or maintenance therapy

The 8th Biennial Meeting of the Asian Society of Gynecologic Oncology, December 1st to 3rd, 2023

Olaparib plus Durvalumab, with or without Bevacizumab, as Treatment in PARP Inhibitor-Naïve Platinum-Sensitive Relapsed Ovarian Cancer: A Phase II Multi-Cohort Study

Comparison of survival and complications between minimally invasive and open staging surgeries in non-endometrioid endometrial cancer

Analysis of East Asia subgroup in Study 309/KEYNOTE-775: lenvatinib plus pembrolizumab versus treatment of physician’s choice chemotherapy in patients with previously treated advanced or recurrent endometrial cancer

Clinical Trial Protocol for ROSELLA: a phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer

Stratifying the risk of ovarian cancer incidence by histologic subtypes in the Korean Epithelial Ovarian Cancer Study (Ko‐EVE)

The Asia-Pacific Gynecologic Oncology Trials Group (APGOT): building a Pan-Asian and Oceania women’s cancer research organization

The Asia-Pacific Gynecologic Oncology Trials Group (APGOT): building a Pan-Asian and Oceania women’s cancer research organization

Biomarker-guided targeted therapy in platinum-resistant ovarian cancer (AMBITION; KGOG 3045): a multicentre, open-label, five-arm, uncontrolled, umbrella trial

EPIK-O/ENGOT-OV61: alpelisib plus olaparib vs cytotoxic chemotherapy in high-grade serous ovarian cancer (phase III study)

Book Review: IARC handbooks of cancer prevention, volume 18: Cervical cancer screening

Major clinical research advances in gynecologic cancer in 2021

Lymph Node Ratio Is a Strong Prognostic Factor in Patients with Early-Stage Cervical Cancer Undergoing Minimally Invasive Radical Hysterectomy

Major clinical research advances in gynecologic cancer in 2020

Post-LACC era: critical assessment not “all-or-none” is needed

Collaborators (24)

Patricia Roxburgh

Jeong-Yeol Park

Tae Hun Kim

Taek Sang Lee

Sooyoung Hur

Seung-Hyuk Shim

Philip Beale

Charles Leath III

David SP Tan

yvette drew

Seock-Ah Im

Yoo-Young Lee

Jong-Min Lee

Ruth Plummer

Jae-Hoon Kim

Junsik Park

Jae Kwan Lee

Young Tae Kim

Maria Lee

Sunghoon Kim

Eunhyang Park

Jung Bok Lee

Jung-Yun Lee

YONGSANG SONG

Make your next move.